MedPath

Powered Echelon Device in VATS Surgery

Completed
Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions
Device: Endocutter
Registration Number
NCT01843192
Lead Sponsor
Ethicon Endo-Surgery
Brief Summary

This study aims to collect real world outcomes of Video-Assisted Thoracoscopic Surgery (VATS) for lung cancer (lobectomy, wedge resection) using ECHELON FLEX™ Powered ENDOPATH® Staplers 45 mm and/or 60 mm (study devices).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Suspected or confirmed NSCLC (up to and including Stage II)
  • Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
  • Performance status 0-1 (Eastern Cooperative Oncology Group classification)
  • ASA score < 3
  • No prior history of VATS or open lung surgery
  • Willing to give consent and comply with study-related evaluation and treatment schedule
Exclusion Criteria
  • Active bacterial infection or fungal infection;
  • Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
  • Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
  • Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed)
  • Pregnancy
  • Physical or psychological condition which would impair study participation;
  • The patient is judged unsuitable for study participation by the Investigator for any other reason; or
  • Unable or unwilling to attend follow-up visits and examinations

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
VATS for suspected or confirmed NSCLCEndocutterSingle arm study
Primary Outcome Measures
NameTimeMethod
Occurrence of Prolonged Air LeaksPost-operative period through hospital discharge and follow-up at Day 30

Prolonged air leaks defined as longer than 5 days in continuous duration. Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).

Occurrence of Postoperative Air LeaksPost-operative period through hospital discharge and follow-up at Day 30

Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).

Secondary Outcome Measures
NameTimeMethod
Operative TimeDay of surgery

Defined as the duration in hours from the first skin incision to the closure of the last incision

Occurrence of Intra-operative Leak TestDuring surgery

This outcome was scored as Yes or No based on whether a leak was detected during an intra-operative leak test when it was performed. Not all subjects had an intra-operative leak test performed, as it was not standard of care at all participating institutions, and so results are only presented for those subjects in whom an intra-operative test was performed.

Time to Chest Tube RemovalPost-operative period through hospital discharge and follow-up at Day 30

Defined as the number of days from date of surgery to removal of the last chest tube inserted during the surgical procedure.

Length of Stay (LOS)Post-operative period through hospital discharge and follow-up at Day 30

Determined as the length of time in days from hospital admission to initial hospital discharge

Volume of Estimated Intra-operative Blood LossBlood loss intra-op and up to 5 days post-op
Number of Subjects With 1 Chest Tube PlacedDuring surgery

All subjects had either 1 or 2 chest tubes placed during surgery. Results presented are for the percentage of subjects with 1 chest tube placed.

Trial Locations

Locations (4)

Dignity Health, St. Joseph's Hospital & Medical Center

🇺🇸

Phoenix, Arizona, United States

Washington University School of Medicine

🇺🇸

St. Louis, Missouri, United States

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath